Related Experiment Video
Updated: May 3, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
Post-β-lactamase-inhibitor effect of tazobactam in combination with ceftolozane on
Helio S Sader1, Paul R Rhomberg, Ronald N Jones
1JMI Laboratories, North Liberty, Iowa, USA.
Abstract:
The post-β-lactamase-inhibitor effect (PBLIE) of tazobactam combined with ceftolozane was evaluated by time-kill assays on two clinical Escherichia coli strains producing CTX-M-15 with or without TEM-1. The organisms were exposed (2 h) to 4 μg/ml/4 μg/ml of ceftolozane-tazobactam (4× MIC), 4 μg/ml of ceftolozane, and medium containing no drug, washed, and resuspended in medium alone or medium containing ceftolozane-tazobactam or ceftolozane. The PBLIE was determined as 1.3 to 2.1 h, and a postantibiotic effect was measured as 0.8 to 0.9 h.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
Inhibitors of Gram-positive Cell Wall Synthesis
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Antimicrobial Effectiveness

